Lymphoma is a medical condition with active clinical research programs worldwide.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID	Title	Status	Phase
NCT01216683	Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma	COMPLETED	PHASE2
NCT00897767	Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial	COMPLETED	—
NCT01190449	Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma	COMPLETED	PHASE2
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—
NCT00274924	Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma	COMPLETED	PHASE2
NCT01132807	Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma	COMPLETED	PHASE2
NCT00719563	American Ginseng in Treating Patients With Fatigue Caused by Cancer	COMPLETED	PHASE3
NCT01415752	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma	ACTIVE_NOT_RECRUITING	PHASE2
NCT00075946	Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma	COMPLETED	PHASE3
NCT00822120	S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma	COMPLETED	PHASE2

Related Pages

All Lymphoma trials All trials in Weston, United States